Al Balwi Mohammed A, Hadadi Ali I, Alharbi Wardah, Ballow Mariam, AlAsiri Abdulrahman, AlAbdulrahman Abdulkareem, G K Udayaraja, Aldrees Mohammed, AlAbdulkareem Ibrahim, Hajeer Ali H
Pathology and Laboratory Medicine Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Medical Genomics Research Department, King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Hum Immunol. 2017 Apr;78(4):384-386. doi: 10.1016/j.humimm.2017.03.003. Epub 2017 Mar 7.
To investigate the extent of CCR5 polymorphism in the healthy Saudi population.
A total of 321 healthy Saudi individuals were sequenced using the ion Ampliseq™ Exome kit (Life Technologies, USA) on genomic DNA following manufacturer's protocol. Whole Exome Sequencing (WES) reads were aligned to the human reference genome (hg19 build) with Torrent Suite Software (v5.0.2) and the variants were called using the Torrent Variant Caller plugin (v5.0) and imported into Ion Reporter Server (v5.0) for the annotation. CCR5 coding exons variants were filtered and checked against the NHLBI GO Exome Sequencing Project (NHLBI), NCBI Reference dbSNPs database, 1000 genomes and Exome Aggregation Consortium datasets (ExAC).
A total of 475 variants were identified. Table 1 shows polymorphisms/mutations detected within exons that introduced an amino acid change, deletion or copy number variants (CNV). Three mutations are predicted to influence CCR5 function, including the 32bp deletion (Rs333). Four polymorphisms were detected, plus two CNV.
This is the first report on sequencing the full CCR5 gene using NGS in the Saudi population. Here we demonstrate seven polymorphisms/mutations that were reported before. All were detected within very low frequency including the delta 32 mutation. However, we report for the first time copy number variants at two CCR5 gene locations; 45072265 and 38591712.
研究健康沙特人群中CCR5基因多态性的程度。
按照制造商的方案,使用Ion Ampliseq™外显子组试剂盒(美国赛默飞世尔科技公司)对321名健康沙特个体的基因组DNA进行测序。使用Torrent Suite软件(v5.0.2)将全外显子组测序(WES)读数与人类参考基因组(hg19版本)比对,并使用Torrent Variant Caller插件(v5.0)调用变体,然后导入Ion Reporter Server(v5.0)进行注释。对CCR5编码外显子变体进行筛选,并与美国国立卫生研究院心肺血液研究所外显子组测序计划(NHLBI)、美国国立生物技术信息中心参考单核苷酸多态性数据库(dbSNPs)、千人基因组计划和外显子聚合联盟数据集(ExAC)进行比对。
共鉴定出475个变体。表1显示了在外显子内检测到的导致氨基酸变化、缺失或拷贝数变体(CNV)的多态性/突变。预测有三个突变会影响CCR5功能,包括32bp缺失(Rs333)。检测到四个多态性,外加两个CNV。
这是沙特人群中首次使用二代测序技术对完整CCR5基因进行测序的报告。我们在此展示了之前报道过的七种多态性/突变。所有这些多态性/突变的检测频率都非常低,包括Δ32突变。然而,我们首次报告了CCR5基因两个位置的拷贝数变体;45072265和38591712。